SCHEMBL13613614

SCHEMBL13613614

COc1ccc(CNC(=O)Nc2cccc3c2CC(O)CC3)cc1

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
KMT2A Q03164 1/20 0.56
TRPV1 Q8NER1 12/20 0.50
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
OPRM1 P35372 1/20 0.47
SNCA P37840 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2734754 0.97 KDM4E (0.53) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL2733717 0.90 TRPV1 (0.50) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL13613633 0.90 ALDH1A1 (0.50) MEN1ALDH1A1KMT2ATRPV1SMN1; SMN2
SCHEMBL13613643 0.89 TRPV1 (0.48) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL2734530 0.88 L3MBTL1 (0.48) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL13613609 0.88 TRPV1 (0.51) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL4333843 0.87 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL4333848 0.87 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613647 0.87 GAA (0.56) KDM4EMEN1ALDH1A1KMT2ATRPV1
SCHEMBL4338606 0.87 TRPV1 (0.53) TRPV1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed